Form D · Biotechnology
RainBio, Inc.
Raleigh, NC · CIK 0001834216
Offering snapshot reported Dec 8, 2020 · SEC filing
- Reported sold
- $50K Offering amount: $500K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 29, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2020 | Initial | $50,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-382568
Source: Form D, filed Dec 8, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Gilger | Director, Executive, Promoter |
| Matthew Hirsch | Director, Promoter |
| Frances Martin | Director, Executive, Promoter |
| Benjamin Yerxa | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8628 Valley Brook Drive
Raleigh, NC, 27613
Raleigh, NC, 27613